CEO
Clay has over 20 years experience in operations and management in the Medical Device and Tissue Bank industries. Clay co-founded and developed the Reglera division of Enscicon, and has since developed Reglera into a multi-million dollar a year business with a strong and diverse client base.
As CEO of Reglera, Clay is responsible for strategy development for Reglera. Reglera's product and services mix is a result of his experience in the Medical Device and Tissue Banking industries and reflects his vision to provide companies with solutions, not simply advice. From its launch, Clay has lead and developed the organization into one of the largest and fastest growing consulting / outsourcing companies in its marketplace. Reglera was recognized by Inc. Magazine in 2005 as #43 in the list of 100 fastest growing inner city companies in America.
Before joining Enscicon / Reglera, Clay worked for COBE Laboratories / GAMBRO Healthcare. As a part of their US Corporate Management Team, he supported GAMBRO Healthcare’s rapid growth from several hundred million to greater than $1 billion in annual revenues. Rising quickly from a top technical contributor to a position as Corporate Director of Quality Assurance, Clay’s organization led the company to establish world-class quality systems and successfully resolved chronic problems with the FDA that threatened to close the company’s US operations. Before his work at GAMBRO, Clay worked with Alcon Laboratories and helped develop and introduce two of the most successful ophthalmic surgical instruments ever brought to the market.